BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...

BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership with ML Tech to optimize the BGLC’s ...

Ethereum [ETH] ETF flows turned positive after 10 days of an outflow trend, signaling a likely renewed demand for the altcoin ...

BioNexus Gene Lab Corporation, a leading medical laboratory services provider, has made history by becoming the first ...

Medical technology company BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced the adoption of Ethereum (CRYPTO: ETH) as ...

To provide transparency and further insight into this decision, BGLC has published its Ethereum Strategy Whitepaper, which is now available to the public. This document outlines Ethereum’s role as a ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

KUALA LUMPUR – BioNexus Gene Lab Corp (NASDAQ:BGLC), a medical laboratory services provider with a market capitalization of $6.83 million and a current stock price of $0.37, has made significant ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

BioNexus Gene Lab stock hits 52-week low at $0.22 BioNexus Gene Lab Corporation (BGLC) shares tumbled to a 52-week low, touching down at $0.22, with a price-to-book ratio of just 0.5. The ...